Search

Your search keyword '"Eilber, U."' showing total 143 results

Search Constraints

Start Over You searched for: Author "Eilber, U." Remove constraint Author: "Eilber, U."
143 results on '"Eilber, U."'

Search Results

1. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

2. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

3. Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors

4. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium

5. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium

6. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

7. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

8. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium

9. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

10. Association analysis identifies 65 new breast cancer risk loci

11. Gene-environment interactions involving functional variants

12. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

13. Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium

14. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

17. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

18. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

19. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci

20. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

21. Genome-wide significant risk associations for mucinous ovarian carcinoma

22. Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study

23. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

24. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

25. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study

26. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

27. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

28. Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

29. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer

30. Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study

31. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer

32. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

33. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

34. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

35. Prediction of breast cancer risk based on profiling with common genetic variants

36. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

37. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

38. Fine-scale mapping of the 4q24 locus identifies & pr two Independent loci associated with breast cancer risk

39. A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density

40. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

41. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

42. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

43. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

44. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

45. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

46. Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk

48. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors

49. Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors

50. Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome

Catalog

Books, media, physical & digital resources